Zacks.com on MSN11h
AbbVie Stock Declines as Schizophrenia Studies Fail, BMY Gains
ABBV stock tumbles 13% after two mid-stage schizophrenia studies on emraclidine fail to meet their primary endpoint. BMY ...
Here's Why Investors Should Avoid ZTO Express Stock Now
The surge in operating expenses does not bode well for ZTO. A highly competitive environment hurts the company's prospects.
Zacks.com on MSN12h
Should AMAT Stock be Part of Your Portfolio Ahead of Q4 Earnings?
Applied Materials AMAT is scheduled to report fourth-quarter fiscal 2024 results on Nov. 14. For the fiscal fourth quarter, AMAT expects net sales of $6.93 billion (+/-$400 million). The Zacks ...
Zacks.com on MSN4dOpinion
Retail Earnings Loom: A Closer Look
Home Depot HD is on track to kick off the Q3 earnings season for the conventional brick-and-mortar retailers this week, with ...
Reuters on MSN5d
How Musk's clout with Trump could enrich his companies
Elon Musk’s backing of Donald Trump’s decisive victory for a second presidency gives the billionaire entrepreneur ...
Space.com1d
Space pictures! See our space image of the day
Take a look at our favorite space pictures here, and if you're wondering what happened to today in space history don't miss our On This Day in Space video show here! Monday, November 11 ...